Is Adapthealth Corp (AHCO) overvalued? · P/E 16, rev $1.42B
Adapthealth Corp (AHCO) is a medical devices company listed on US.
This page asks whether Adapthealth Corp (AHCO) looks expensive on cached numbers — not a short thesis.
Latest reported AHCO revenue for 2026-06-30 was $1.42B. Net income was -$150.0M. Revenue was up 73.2% from 2026-03-31 to 2026-06-30. AHCO currently screens at market cap $1.26B and trailing P/E 16.1.
AHCO currently screens at market cap $1.26B and trailing P/E 16.1. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AHCO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AHCO stock page for the full model, not this heading.
Not investment advice.